Almost 20% of unvaccinated Americans still prefer J&J Covid vaccine after U.S. pause, survey showsCNBC • 05/04/21
Week In Review: CANbridge Licenses LogicBio's Adeno-Associated Virus For Gene Therapies In $591 Million DealSeeking Alpha • 05/03/21
3 Reasons Not to Buy Johnson & Johnson Stock Just Because Its COVID Vaccine Pause Was LiftedThe Motley Fool • 04/27/21
Procter & Gamble Vs. Johnson & Johnson: The Battle Of Dividend Royalty - Dividend Stock AnalysisSeeking Alpha • 04/26/21